Facebook Linkedin Twitter
Inside Precision Medicine Predicting the Risk of Relapse in Early-Stage Melanoma

Melanoma

Asked & Answered column photo
News & Features

Predicting the Risk of Relapse in Early-Stage Melanoma

Damian Doherty
0
3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency
News & Features

BioNTech’s mRNA Vaccine Combo Scores in Phase II

0
Human kidney cross section on scientific background
News & Features

Microbiome Pill Could Boost Kidney Cancer Responses

0
ribonicleic acid chain from which can be used to make RNA silencing treatments for conditions such as congenital melanocytic nevus syndrome
News & Features

RNA Silencing Therapy Could Help Treat Rare Skin Condition

0
Cancer cells
News & Features

AI-Powered Liquid Biopsy Delivers Ultrasensitive Cancer Detection

0
Microglial cell, illustration
Informatics

Druggable Target for Anti–PD-1 Immunotherapy Induced Neurotoxicity Identified

0
Cancer patient in oncology unit
News & Features

New Model Provides Theoretical Foundation for Adaptive Cancer Treatment Strategies

0
3D rendered Illustration of T-Cells of the immune System attacking growing Cancer cells. Gamma delta T cells engineered to attack solid tumors
News & Features

Flipping the Switch on Checkpoint Protein That Turns off T Cells During Immunotherapy

0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Rare Nail Condition Greatly Increases Cancer Risk

0
CAR T cell immunotherapy
News & Features

New Technique Improves T Cell-Based Immunotherapies for Solid Tumors

Alice McCarthy
0
123...14Page 2 of 14

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine